Aarti Drugs reports strong Q3 profit and announces buyback
after close1 source ↓written by the desknot a recommendation
Aarti Drugs reported robust profit growth for Q3 FY26, with strong revenue figures and a declared interim dividend. The company successfully completed a share buyback and commenced operations at a new plant in Gujarat, bolstering its future growth prospects. New senior management appointments further support strategic initiatives.
Not investment advice. For informational purposes only.